Close
Smartlab Europe
Inizio Ignite

Featured

Faster Access Via Recognition Routes – Initiative By MHRA

The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established by making use of approvals from Singapore, Canada, Japan, the US, Australia, Switzerland, and, of...

Mixed Reactions From Scientists As AI Emerges Pharma Sector

Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there happens to be a bifurcation of attitudes, with some researchers pretty much excited when it...

Blockchain Technology And Quality Control In Pharma Industry

In late 2020, Pfizer, a drug manufacturer, faced challenges in meeting its Covid-19 vaccine production targets due to quality issues with raw materials, causing disruptions in the global supply chain. The situation worsened in March 2021 when contamination issues...

Blockchain Revolutionizes Pharma Operations And Profits

The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as well as marketing drugs and other pharmaceutical products. That said, it faces loads of challenges...

Safe And Efficient Gene Editing With Virus-Derived Peptides

A novel approach within the genetic engineering of cells promises major enhancements when it comes to speed, effectiveness, and reduction in cellular toxicity as compared to the current methods. The approach could also go on to power advanced cell...

Complexity of APIs Drive OSD Contract Manufacturing Demand

For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient delivery of drugs to the intended site where action needs to happen. Nevertheless, the demand...

Digital Bioprocessing Is Set To Improve Drug Product Quality

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation. The influencing factors identified...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »